PAIOF (PAIOF) Stock Price & Analysis
PAIOF (PAIOF) rose 0.00% to USD 0.01 as of June 10, 2026 at 00:25 UTC, according to Nexqual real-time market data.
PAIOF last closed at USD 0.01; the session ranged USD 0.05–0.05 on volume of 30,000 shares. Market capitalization is $75,263, with a 52-week range of USD 0–0.05 (PNK). Source: Nexqual, June 10, 2026 at 00:25 UTC.
Key Statistics (as of June 10, 2026 at 00:25 UTC)
| Price | USD 0.01 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.01 |
| Open | USD 0.05 |
| Day Range | USD 0.05 – 0.05 |
| 52-Week Range | USD 0 – 0.05 |
| Volume | 30,000 shares |
| Market Cap | $75,263 |
| Exchange | PNK |
Technical Analysis (PAIOF)
Nexqual's technical model rates PAIOF "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:25 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0.01) |
| MACD | 0 (negative) |
Analyst Ratings (PAIOF)
Wall Street analysts rate PAIOF "None", per Nexqual as of June 10, 2026 at 00:25 UTC.
| Consensus Rating | None |
|---|
Earnings (PAIOF)
Source: Nexqual, June 10, 2026 at 00:25 UTC.
Financials & Fundamentals (PAIOF)
| Total Revenue | $14.81M |
|---|---|
| Revenue Growth (YoY) | +21.40% |
| Gross Margin | +57.15% |
| Operating Margin | -83.60% |
| Profit Margin | -134.12% |
| ROE | -288.71% |
| Current Ratio | 0.76 |
| Total Cash | $4.65M |
| Total Debt | $21.25M |
| Free Cash Flow | $-7.47M |
Source: Nexqual, June 10, 2026 at 00:25 UTC.
Financial Health Score (PAIOF)
Nexqual rates PAIOF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 00:25 UTC.
| Growth | Strong — Revenue +366% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $5M cash vs $21M debt |
| Cash Flow | Weak — FCF negative: -$7M, burning cash |
| Efficiency | Critical — ROE -289%, ROA -27.1% |
Ownership (PAIOF)
| Insider Ownership | +9.09% |
|---|---|
| Institutional Ownership | +1.15% |
| Shares Outstanding | 7.53M |
| Float | 6.49M |
Source: Nexqual, June 10, 2026 at 00:25 UTC.
Leadership (PAIOF)
PAIOF is led by Gregor Siebert, Chairman of Management Board & CEO, per Nexqual as of June 10, 2026 at 00:25 UTC.
| Chairman of Management Board & CEO | Gregor Siebert |
|---|---|
| Member of Management Board & CFO | Sebastian Werner |
| Vice President of Investor Relations & Public Relations | Ralf Penner |
| Senior Vice President of Development | Thomas Stoehr |
Major Backers & Investors (PAIOF)
Notable institutional backers of PAIOF include College Retirement Equities Fund-Stock Account, according to Nexqual as of June 10, 2026 at 00:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| College Retirement Equities Fund-Stock Account | 0.29% |
Source: Nexqual, June 10, 2026 at 00:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AGYTF | ALLERGY THERAPEUTICS | USD 0.13 | ▲ 0% |
| ACBM | ACRO BIOMEDICAL CO LTD | USD 0.03 | ▲ 0% |
| AFMJF | Alphamin Resources Corp. | USD 0.98 | ▼ 2.5% |
| DUSXF | DUSTIN GROUP AB | USD 0.17 | ▲ 0% |
| FUVV | Arcimoto, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:25 UTC. This page is informational and not investment advice.